1. PH-0113 Anti-Epidermal Growth Factor Receptor Therapy in combination with Chemoradiotherapy for the Treatment of Locally Advanced Anal Canal Carcinoma: Results of a Phase II Study with Panitumumab (FFCD 0904). (August 2021) Authors: Vendrely, V.; Ronchin, P.; Le-Malicot, K.; MINSAT, M.; Lemanski, C.; MIRABEL, X.; LIEVRE, A.; DARUTJOUVE, A.; DE LA Fouchardiere, C.; Breysacher, G.; Argo-Leignel, D.; Thimonier, E.; Magne, N.; Belletier, C.; Lepage, C.; Aparicio, T. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗